Cargando…
20(S)-Ginsenoside Rg(3) is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. High mortality from HCC is mainly due to widespread prevalence and the lack of effective treatment, since systemic chemotherapy is ineffective, while the targeted agent Sorafenib extends median survival on...
Autores principales: | Kim, Dong-Gun, Jung, Kyung Hee, Lee, Da-Gyum, Yoon, Jung-Ho, Choi, Kyeong Sook, Kwon, Sung Won, Shen, Han-Ming, Morgan, Michael J., Hong, Soon-Sun, Kim, You-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147336/ https://www.ncbi.nlm.nih.gov/pubmed/24970805 |
Ejemplares similares
-
Activation of Ca(2+)‐AMPK‐mediated autophagy by ginsenoside Rg3 attenuates cellular senescence in human dermal fibroblasts
por: Kim, Dasol, et al.
Publicado: (2021) -
Ginsenoside Rg1 and 20(S)-Rg3 Induce IgA Production by Mouse B Cells
por: Park, Ha-Yan, et al.
Publicado: (2015) -
Upregulation of autophagy by Ginsenoside Rg2 in MCF-7 cells
por: Chung, Yuheon, et al.
Publicado: (2018) -
20(S)-Ginsenoside Rg3 Promotes HeLa Cell Apoptosis by Regulating Autophagy
por: Bian, Shuai, et al.
Publicado: (2019) -
Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity through the Inhibition of Autophagy and Endoplasmic Reticulum Stress in Mice
por: Xu, Zhi-Meng, et al.
Publicado: (2018)